News
TXG
36.87
-0.75%
-0.28
Weekly Report: what happened at TXG last week (0622-0626)?
Weekly Report · 1d ago
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
Reuters · 1d ago
10x Genomics (TXG) Is Up 5.7% After Cleveland Clinic Precision-Oncology Biomarker Collaboration News - What's Changed
Simply Wall St · 2d ago
Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor
Barchart · 4d ago
Merck's Bio-Techne buyout put Life Sciences sector in focus: top quant-rated stocks
Seeking Alpha · 4d ago
10x Genomics CEO Serge Saxonov sells 30,000 shares for $1.04 million
PUBT · 5d ago
10x Genomics Is Maintained at Overweight by Barclays
Dow Jones · 6d ago
Barclays Maintains Overweight on 10x Genomics, Raises Price Target to $40
Benzinga · 6d ago
10X GENOMICS <TXG.O>: BARCLAYS RAISES TARGET PRICE TO $40 FROM $30
Reuters · 6d ago
10x Genomics price target raised to $40 from $30 at Barclays
TipRanks · 6d ago
Barclays Reaffirms Their Buy Rating on 10x Genomics (TXG)
TipRanks · 6d ago
U.S. RESEARCH ROUNDUP-Bank of America, FedEx, JPMorgan
Reuters · 6d ago
Cathie Wood's Ark Invest weekly recap: Block and Snowflake bought, Roku and Strata liquidated
Seeking Alpha · 06/22 11:00
Weekly Report: what happened at TXG last week (0615-0619)?
Weekly Report · 06/22 09:20
10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics
NASDAQ · 06/19 14:31
10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?
Barchart · 06/19 04:44
How 10x Genomics’ (TXG) Cleveland Clinic Pact Could Reframe Its Precision Oncology Ambitions
Simply Wall St · 06/19 03:52
10x Genomics director Shehnaaz Suliman sells $186,818 of common shares
PUBT · 06/18 20:08
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
Reuters · 06/18 07:14
10X GENOMICS INC <TXG.O>: JEFFERIES RAISES TARGET PRICE TO $40 FROM $26
Reuters · 06/18 04:08
More
Webull provides a variety of real-time TXG stock news. You can receive the latest news about 10X Genomics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TXG
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.